The primary aim is to test whether abatacept, as compared to placebo, is associated with a reduction in major adverse cardiac events (MACE) among participants hospitalized with myocarditis secondary to an immune checkpoint inhibitor (ICI).

This study is to see if a special type of ultrasound can detect fluid in lungs, with the ultimate goal that maybe this ultrasound technique can be used in the future to help patients with heart failure.

The objectives of this pivotal clinical trial are to evaluate the safety and effectiveness of the PASCAL System for transcatheter tricuspid valve repair with OMT (optimal medical therapy) compared to OMT alone in the treatment of patients with symptomatic severe tricuspid regurgitation.

The purpose of this registry is to observe outcomes of heart transplant recipients who are managed with HeartCare. This is done by collecting information about your heart transplant such as test results, biopsy results, and outcomes, storing that information in a database, and using that information for research.

This study is designed to assess the effect of AZD0780 compared with placebo in reducing the risk of major cardiovascular events (MACE)-PLUS in patients with established ASCVD or those at high risk for a first ASCVD event.